First Manhattan’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,500
| Closed | -$27.6K | – | 1531 |
|
|
2022
Q4 | $27.6K | Hold |
6,500
| – | – | ﹤0.01% | 1041 |
|
|
2022
Q3 | $31K | Hold |
6,500
| – | – | ﹤0.01% | 1010 |
|
|
2022
Q2 | $19K | Hold |
6,500
| – | – | ﹤0.01% | 1114 |
|
|
2022
Q1 | $17K | Hold |
6,500
| – | – | ﹤0.01% | 1185 |
|
|
2021
Q4 | $19K | Hold |
6,500
| – | – | ﹤0.01% | 1174 |
|
|
2021
Q3 | $31K | Hold |
6,500
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q2 | $25K | Hold |
6,500
| – | – | ﹤0.01% | 1116 |
|
|
2021
Q1 | $30K | Buy |
+6,500
| New | +$30K | ﹤0.01% | 1062 |
|
|
2019
Q4 | – | Sell |
-200
| Closed | – | – | 1292 |
|
|
2019
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 1317 |
|
|
2019
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 1361 |
|
|
2019
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 1382 |
|
|
2018
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 1357 |
|
|
2018
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 1387 |
|
|
2018
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 1345 |
|
|
2018
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 1369 |
|
|
2017
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 1439 |
|
|
2017
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 1423 |
|
|
2017
Q2 | $0 | Hold |
200
| – | – | ﹤0.01% | 1386 |
|
|
2017
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 1383 |
|
|
2016
Q4 | $1K | Sell |
200
-2,400
| -92% | -$12K | ﹤0.01% | 1325 |
|
|
2016
Q3 | $10K | Hold |
2,600
| – | – | ﹤0.01% | 1180 |
|
|
2016
Q2 | $8K | Hold |
2,600
| – | – | ﹤0.01% | 1253 |
|
|
2016
Q1 | $7K | Hold |
2,600
| – | – | ﹤0.01% | 1204 |
|
|
2015
Q4 | $7K | Hold |
2,600
| – | – | ﹤0.01% | 1219 |
|
|
2015
Q3 | $12K | Buy |
+2,600
| New | +$12K | ﹤0.01% | 1154 |
|